Ignite Creation Date:
2025-12-24 @ 7:17 PM
Ignite Modification Date:
2025-12-27 @ 5:34 AM
Study NCT ID:
NCT00381303
Status:
COMPLETED
Last Update Posted:
2014-04-21
First Post:
2006-09-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.
Sponsor:
Tibotec, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR011869
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |